G6PD Deficiency

Oncology·MeSH: Hyperphenylalaninemia, BH4-Deficient, B

Prevalence

5880.7 / 100K

Incidence

109.8 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target G6PD Deficiency?

There are 2 clinical trials targeting G6PD Deficiency tracked by BioSniper.

What is the prevalence of G6PD Deficiency?

The estimated prevalence of G6PD Deficiency is approximately 5880.7 per 100,000 population.

Deep-dive into G6PD Deficiency

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    G6PD Deficiency — Drugs in Development & Clinical Trials | BioSniper